Purpose

The purpose of this clinical trial is to assess if donor site healing in the palatal area and patient pain perception are similar or different when using amnio-chorion membrane (ACM) on the donor site after surgery compared to a commonly used commercial hemostatic agent (ActCel Cellulose Gauze).

Condition

Eligibility

Eligible Ages
Between 18 Years and 89 Years
Eligible Genders
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Patients between age 18 and 89 - Patients needing an FSTA in the area of the mouth from 2nd molar to 2nd molar in the maxilla or mandible at sites that have teeth or implants, or in sites that are edentulous - Patients must be nonsmokers, former smokers, or current smokers who smoke <10 cigarettes per day, by self-report - Female patients who have undergone a hysterectomy, tubal ligation, or menopause, and non- pregnant women of child-bearing potential. - Must have access to Smartphone

Exclusion Criteria

  • Patients who disclose that they will not be able to cooperate with the follow-up schedule. - Patients who are mentally incompetent, prisoners, or pregnant (as obtained via chart review or self-report) - Pregnant women or women intending to become pregnant during study period - Smokers who smoke > 10 cigarettes per day

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Intervention Model Description
This is a two-independent arm, parallel-design randomized, prospective trial designed to compare two standard of care techniques.
Primary Purpose
Treatment
Masking
Single (Participant)
Masking Description
Participants will be randomly assigned to either the hemostatic agent or the amnio-chrionic membrane, but will be blinded to which standard of care intervention to which they are assigned.

Arm Groups

ArmDescriptionAssigned Intervention
Active Comparator
Use Amnio Chorion Membrane (ACM) with hemostatic agent
ACM or amnion-only membranes have been used in oral surgical procedures primarily because they contain a host of growth factors that play a role in normal wound healing.
  • Other: Amnion-chorion Membrane
    Amnio-chorion membranes specifically for palatal wound healing following free soft tissue autografts (FTSA) procedures.
    Other names:
    • ACM
  • Other: ActCel Cellulose Gauze
    When these products come in contact with blood, they convert to a gel that expands to cause direct pressure on blood vessels and control bleeding. ActCel is water-soluble and dissolves over a short time period. It can be removed easily when water, saline or hydrogen peroxide is applied.
    Other names:
    • Hemostatic agent
Placebo Comparator
Use of ActCel Cellulose Gauze (Commercial Hemostatic Agent)
Palatal wound dressing with hemostatic agent
  • Other: ActCel Cellulose Gauze
    When these products come in contact with blood, they convert to a gel that expands to cause direct pressure on blood vessels and control bleeding. ActCel is water-soluble and dissolves over a short time period. It can be removed easily when water, saline or hydrogen peroxide is applied.
    Other names:
    • Hemostatic agent

Recruiting Locations

University of Texas Health Science Center at San Antonio (Dental School)
San Antonio, Texas 78229
Contact:
Brian L Mealey, DDS, MS
210-567-3589
mealey@uthscsa.edu

More Details

Status
Recruiting
Sponsor
The University of Texas Health Science Center at San Antonio

Study Contact

Brian Mealey, DDS, MS
210-450-8736
mealey@uthscsa.edu

Detailed Description

Resorbable oxidized cellulose materials are commonly used as hemostatic agents in medicine and dentistry. Surgicel and ActCel are used daily in surgical practice. When these products come in contact with blood, they convert to a gel that expands to cause direct pressure on blood vessels and control bleeding. ActCel is water-soluble and dissolves over a short time period. It can be removed easily when water, saline or hydrogen peroxide is applied.The study team will examine the effects of ACM as a wound dressing for the donor area and compare the rate of epithelialization with and without its use.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.